Cipta Sarana Medika Tbk. vs SLJ Global Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while SLJ Global Tbk. trades at Rp79 (market cap 493.02B, 915.7K 24h volume). The key difference: SLJ Global Tbk. is far larger — about 3.1× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 915.7K). Which is the better fit depends on your goals.
| DKHH | SULI | |
|---|---|---|
Market Cap | 158.12B | 493.02B |
Volume | 8.21M | 915.7K |
Lot | 82.15K | 9.16K |
Turnover | 515.2M | 72.1M |
Average Price | 62.72 | 78.74 |
Value | 515.2M | 72.1M |
Indicative Equilibrium Price | 63 | 79 |
Indicative Equilibrium Volume | 1.33K | 420 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT SLJ Global (the Company) was established under the name of PT. Sumalindo Lestari Jaya in the Republic of Indonesia based on Notarial Deed No. 10 dated April 14, 1980, of Rukmasanti Hardjasatya , S.H., as amended by Deed No. 1 dated June 3, 1980, of the same notary.
Read more on SULI →